Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rank in Stocks #24449
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Share Price
$0.78611575
Market Cap
$60.45M
Change (1 day)
0.00%
Change (1 year)
-12.06%
Country
NO
Trade Lytix Biopharma AS (LYTIX)

Category

Stock price history for Lytix Biopharma AS (LYTIX)
Highest end of day price: $0.83 on 2026-08-01

Lowest end of day price: $1.84 on 2021-06-01
Stock price history of Lytix Biopharma AS from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$549.84 38.34%
US
$1.05K 58.20%
NL
$150.50 473.99%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH